AU Patent

AU2025263907A1 — Methods of treating and preventing graft versus host disease

Assigned to Pharmacyclics LLC · Expires 2025-12-04 · 0y expired

What this patent protects

METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE Described herein are methods for treating and preventing graft versus host disease using ACK inhibitors. The methods include administering to an individual in need thereof an ACK inhibitor such as ibrutinib for treating…

USPTO Abstract

METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE Described herein are methods for treating and preventing graft versus host disease using ACK inhibitors. The methods include administering to an individual in need thereof an ACK inhibitor such as ibrutinib for treating and preventing graft versus host disease. METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE

Drugs covered by this patent

Patent Metadata

Patent number
AU2025263907A1
Jurisdiction
AU
Classification
—
Expires
2025-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacyclics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.